NCT00003816 arm group 94a8a64712763a5140ba975cf498b4c0 [clinicaltrials_resource:NCT00003816/arm-group/94a8a64712763a5140ba975cf498b4c0]
NCT00003816 arm group 94a8a64712763a5140ba975cf498b4c0 [clinicaltrials_resource:NCT00003816/arm-group/94a8a64712763a5140ba975cf498b4c0]
Bio2RDF identifier
NCT00003816/arm-group/94a8a64712763a5140ba975cf498b4c0
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... a8a64712763a5140ba975cf498b4c0
description [clinicaltrials_vocabulary:description]
Patients receive etoposide IV ...... twice daily on days -3 to -1.
identifier
clinicaltrials_resource:NCT00003816/arm-group/94a8a64712763a5140ba975cf498b4c0
title
NCT00003816 arm group 94a8a64712763a5140ba975cf498b4c0
@en
type
label
NCT00003816 arm group 94a8a647 ...... 8a64712763a5140ba975cf498b4c0]
@en